Gait Characteristics Following a Fall

NCT01631604 | Unknown

• 1 other identifier: Fall-HMO-CTIL
• Study Type: interventional
• Target: N/A
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to quantify the safety degree of the patient's gait, to detect the reason for the fall and quantify the biomechanical parameters related to fall. This study also aims to evaluate the effect of different rehabilitation treatments and their effect on the risk of falling.

Conditions

Motor Impairments; Orthopaedic Injuries; Neurological Conditions

Keywords

risk of falling; gait patterns; muscle activity; fall prevention; motor impairment

Outcome Measures

Primary Outcomes (1)

• Gait kinematics

  Joint angles, velocities and accelerations

Secondary Outcomes (1)

• Muscle activation patterns

Interventions

Walking aids and devices DEVICE

Walking aids, e.g. braces, canes,orthoses, prosthetics, etc.

Muscle/nerve injection DRUG

Injection to muscle or nerve

Also known as: Botulinum toxin, Marcaine

Corrective surgery PROCEDURE

correction of spinal and bony deformities, muscle transfer, tendon elongation etc.

Also known as: Knee arthroscopy, meniscectomy and chondroplasty, Anterior cruciate ligament reconstruction, Knee replacement, Repair of femoral neck fracture, Repair of trochanteric fracture, Debridement of skin/muscle/bone/fracture, Knee arthroscopy repair of both menisci, Hip replacement, Repair of ankle fracture (bimalleolar type), Lumbar spinal fusion, Low back intervertebral disc surgery, Repair of femoral shaft fracture

Physical therapy treatment OTHER

Eligibility Criteria

• Age: 5 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Individuals suffering from gait impairment following injury to the central or peripheral nervous system, as well as following orthopedic injuries. The subjects will be able to understand and independently sign a consent form.

You may not qualify if:

• Subjects who are unable to understand and independently sign a consent form
• Subjects who are wheelchair bound.
• Pregnant women.

Sponsors & Collaborators

• Hadassah Medical Organization: lead

Study Sites (1)

Hadassah Medical Center

Jerusalem, 91240, Israel

Location

MeSH Terms

Interventions

Equipment and Supplies; Botulinum Toxins; Bupivacaine; Meniscectomy; Anterior Cruciate Ligament Reconstruction; Arthroplasty, Replacement, Knee; Arthroplasty, Replacement, Hip; Physical Therapy Modalities

Intervention Hierarchy (Ancestors)

Metalloendopeptidases; Endopeptidases; Peptide Hydrolases; Hydrolases; Enzymes; Enzymes and Coenzymes; Metalloproteases; Bacterial Proteins; Proteins; Amino Acids, Peptides, and Proteins; Bacterial Toxins; Toxins, Biological; Biological Factors; Anilides; Amides; Organic Chemicals; Aniline Compounds; Amines; Orthopedic Procedures; Surgical Procedures, Operative; Arthroplasty; Plastic Surgery Procedures; Arthroplasty, Replacement; Prosthesis Implantation; Therapeutics; Rehabilitation

Study Design

• Study Type: interventional
• Phase: not applicable
• Purpose: TREATMENT
• Intervention Model: FACTORIAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 28, 2012
• First Posted: June 29, 2012
• Study Start: June 1, 2012
• Primary Completion: June 1, 2017
• Study Completion: June 1, 2017
• Last Updated: April 27, 2017

Record last verified: 2012-06

Locations

IL (1)